Thalidomide for the therapy of graft-versus-host disease following allogeneic bone marrow transplantation
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 43 (9) , 693-697
- https://doi.org/10.1016/0753-3322(89)90089-9
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- THALIDOMIDH FOR GRAFT-VERSUS-HOST DISEASEThe Lancet, 1988
- SUCCESSFUL TREATMENT WITH THALIDOMIDE OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATIONThe Lancet, 1988
- Determination of thalidomide and its major metabolites by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1987
- Thalidomide neuropathy: An electrophysiologic studyMuscle & Nerve, 1986
- Treatment of Behçet's disease with thalidomideClinical Rheumatology, 1986
- Thalidomide-induced peripheral neuropathyZeitschrift für Neurologie, 1986
- Thalidomide a promising new treatment for rheumatoid arthritisArthritis & Rheumatism, 1984
- THALIDOMIDE IN THE TREATMENT OF ACTINIC PRURIGOInternational Journal of Dermatology, 1973
- Effect of Thalidomide on the Graft versus Host ReactionNature, 1966
- Prolongation of Skin Homograft Survival by ThalidomideBMJ, 1965